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Introduction / objectives
In July 2010, an increase of IMI was observed in
patients with leukemia and bone marrow transplantation
admitted to the hematology wards at the University of
Geneva Hospitals.
Methods
We conducted a retrospective survey which identified 6
cases of IMI (3 possible and 3 probable) in 2009 and 18
(9 possible, 7 probable and 2 proven) in 2010. All cases
occurred during chemotherapy for acute leukemia, allo-
geneic hematopoietic stem cell transplantation or graft
versus host disease. The incidence of nosocomial IMI
among the at risk population was 3.6 fold higher in
2010 than in 2009.
We aimed to identify any potential failures in the care
of at-risk patients. Additional preventive measures were
set up for isolation rooms and their cleansing, and also
their computer equipment. Protective measures were
instituted for the patients (masks, gowns, caps, food,
objects made available for the patients, transportation).
Standard antifungal prophylaxis was changed from flu-
conazole 100 mg/d to voriconazole 400 mg/d.
Results
The costs of the various preventive measures to stop the
occurrence of new fungal infections were estimated at
2’500’000 CHF (1’900’000 Euros) covering the period
from June, 2010 to June, 2011. This represented an aver-
age of 22’600 CHF (17’176 Euros) per patient admitted.
Of note, 31% of the costs were associated with the
change in antifungal prophylaxis.
To date no new cases have been reported since the
introduction of these measures.
Conclusion
A supplementary review is in progress in order to quan-
tify the overall impact of the preventive measures taken
and to decide which measures should be continued.
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